Published 2024-06-01
Keywords
- Hematopoietic Stem Cell Transplantation,
- Sleep-Wake Disorders,
- Neoplasm,
- Sleep,
- Sleep Initiation and Maintenance Disorders
Copyright (c) 2024 Mayra Veronese, Federica Lacarbonara
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Insomnia has an elevated incidence in patients who receive autologous Hematopoietic Stem Cell Transplantation (HSCT), which can lead to psychic and physical dysfunctions and impair immunological and neuroendocrine processes, hence compromising the response to treatment. The aim of this study is to evaluate the incidence, severity, and changes in time of insomnia in patients following autologous HSCT. Identify the factors affecting the quality of sleep and, in the end, identify the number of nocturnal awakenings and night interruptions by healthcare personnel.
Methods: insomnia was detected through the Insomnia Severity Index (ISI) questionnaire. The questionnaire was handed out in three different periods: on the first day of hospitalization (T0), the day after the transplantation (T1), and at the discharge (T2). The questionnaire was given out at the hematology ward in two hospitals in Italy.
Results: The convenience sample consisted of 31 patients. 42% of patients (N=13) in the pre-hospitalization, 58% (N=18) the day of transplantation, and 65% (N=20) at discharge showed insomnia symptoms: a significant difference between the ISI score at T0 and the ISI score at T1 and T2. There was a relationship between the ISI score and the presence of adverse effects of chemotherapy.
Conclusion: Insomnia is already present in patients following autologous HSCT from pre-admission and worsens during hospitalization. In detecting the symptoms of insomnia, the nurse plays an important role. Multidisciplinary management, both medical and nursing, is essential.
References
- Guariniello LD, Vicari P, Lee KS, de Oliveira AC, Tufik S. Bone marrow and peripheral white blood cells number is affected by sleep deprivation in a murine experimental model. J Cell Physiol. Jan 2012; 227:361-6.
- Die Trill M. Anxiety and sleep disorders in cancer patients. EJC Suppl. 2013; 11:216-24.
- Steiger A, Pawlowski M. Depression and Sleep. International Journal of Molecular Sciences. 2019;20(3):607.
- Zhao M, Tuo H, Wang S, Zhao L. The Effects of Dietary Nutrition on Sleep and Sleep Disorders. Mediators Inflamm. 2020;2020:3142874.
- Klinke R, Pape H-C, Kurtz A, Silbernagl S. PHYSIOLOGIE, VI ed. 2012.
- Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015; 66:143-72.
- Zucconi M, Ferri R. Assessment of sleep disorders and diagnostic procedures. European Sleep Research Society. 2014; 23:95.
- Ghazikhanian SE, Dorfman CS, Somers TJ, O'Sullivan ML, Fisher HM, et al. Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue. Bone Marrow Transplant. 2017;52:279-284. .
- Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012;44:168-80..
- Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG,et al.. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017 Dec;26:675-700.
- Wang XS, Shi Q, Shah ND, Heijnen CJ, Cohen EN, Reuben JM, et al. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014;20(5):1366-74.
- Yavlal F, Aras YG, Ulaş SB. Evaluation of sleep disorders before and after transplantation in patients undergoing hematopoietic stem cell transplantation. Eur Rev Med Pharmacol Sci. 2022; 26:8935-8944.
- Boonstra L, Harden K, Jarvis S, Palmer S, Kavanaugh-Carveth P, et al. Sleep disturbance in hospitalized recipients of stem cell transplantation. Clin J Oncol Nurs. 2011 Jun;15(3):271-6.
- Nelson AM, Coe CL, Juckett MB, Rumble ME, Rathouz PJ, Hematti P, et al. Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates. Bone Marrow Transplant. 2014;49:1405-11.
- Mogavero MP, DelRosso LM, Fanfulla F, Bruni O, Ferri R. Sleep disorders and cancer: State of the art and future perspectives. Sleep Med Rev. 2021; 56:101409.
- Hacker ED, Patel P, Stainthorpe M. Sleep interrupted: nocturnal care disturbances following hematopoietic stem cell transplantation. Clin J Oncol Nurs. 2013; 17:517-23.
- Enderlin CA, Coleman EA, Davila D, Richards K, Jegley SM, Kennedy R, et al. Sleep measured by polysomnography in patients receiving high-dose chemotherapy for multiple myeloma prior to stem cell transplantation. Oncol Nurs Forum. 2013; 40:73-81.
- Jim HS, Evans B, Jeong JM, Gonzalez BD, Johnston L, Nelson AM, et al. Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management. Biol Blood Marrow Transplant. 2014; 20:1465-84
- Palesh O, Peppone L, Innominato PF, Janelsins M, Jeong M, Sprod L, et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2012; 4:151-162.
- Rischer J, Scherwath A, Zander AR, Koch U, Schulz-Kindermann F. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009; 44:121-8.
- Hacker ED, Kapella MC, Park C, Ferrans CE, Larson JL. Sleep Patterns During Hospitalization Following Hematopoietic Stem Cell Transplantation. Oncol Nurs Forum. 2015; 42:371-9.
- Castronovo V, Galbiati A, Marelli S, Brombin C, Cugnata F, Giarolli L, et al. Validation study of the Italian version of the Insomnia Severity Index (ISI). Neurol Sci. 2016 ;37:1517-24.
- Morin CM. Insomnia Severity Index. APA PsycTests. 1993.
- Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2005; 14:429-41.